Clinical Trial Update: A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating tolerability and early efficacy of hLF1-11 in proven candidemia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia

Drugs mentioned

• hLF1-11 (hLF1-11)

Snippet

Sponsor: AM-Pharma | Conditions: Candidaemia | Phase 1, Phase 2 | Status: WITHDRAWN